-

Piper Sandler Expands Biotechnology Equity Research Team with the Addition of Kelsey Goodwin

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Kelsey Goodwin as a director and senior research analyst to the biotechnology equity research team. Goodwin will be based in the Boston office with coverage responsibilities of oncology.

“We are excited to welcome Kelsey to the Piper Sandler platform. She brings a deep understanding and passion for our industry and builds strong relationships to serve clients. We are deeply committed to the biotechnology sector and Kelsey’s addition will only strengthen our industry leading biopharma research practice that is collaborative and energized to provide insights for our clients,” said Michael Cox, co-head of global equities at Piper Sandler.

Prior to joining Piper Sandler, Goodwin spent seven years at Guggenheim, where she focused primarily on the oncology therapeutic area. Before Guggenheim, Kelsey worked in pharmaceutical strategy consulting for three years. Goodwin received a bachelor’s degree in biology from Bowdoin College.

“I am beyond thrilled to join Piper Sandler, a firm with a longstanding reputation not only for its excellence and high-quality research, but also for its people. I look forward to joining the exceptionally talented, hard-working, and collaborative team, and to contributing to the continued success of the firm and its clients,” said Goodwin.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Nick Lawler

Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions
$Cashtags

Contacts

Nick Lawler

Tel: 212 891-8954
nick.lawler@psc.com

Social Media Profiles
More News From Piper Sandler Companies

Piper Sandler Expands Technology Investment Banking Team with the Addition of Anson Tsai

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Anson Tsai as a managing director to its technology investment banking team. He will be based in the Burlingame office. “We are excited to welcome Anson to Piper Sandler. Anson’s sector experience and deep client relationships will have an immediate impact on our fast-growing team. We look forward to seeing his contributions to the firm and our clients,” said Ste...

Piper Sandler Mourns the Loss of Board Member Sherry Smith

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR) is deeply saddened to announce the unexpected passing of Sherry Smith, a valued and respected member of our board of directors. Sherry served as a director of Piper Sandler since 2016 and was a dedicated and insightful leader, who brought a wealth of experience, financial expertise, and unwavering integrity to the firm. Her contributions over the years were incredibly helpful during a period of significant growth. She served as...

Piper Sandler Strengthens Private Capital Advisory Team with Addition of Andy Nick as Co-Head of Secondary Capital Advisory

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Andy Nick as managing director and co-head of secondary capital advisory within the private capital advisory group. Nick will work closely with private equity clients to provide bespoke liquidity and capital solutions, including GP-led continuation funds, fund recapitalizations, and LP portfolio transactions. “Andy is a highly respected advisor with deep relationshi...
Back to Newsroom